Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
Personally the longer we spend around 400 (give or take 5% in either direction) the more we are building a great floor to launch from.
There are huge contracts up for grab out there globally, and some of the best ones are on our doorstep. If people can't see the revenue that's coming NCYT's way they are blind. But it creates and opportunity for the rest of us.
It will be a simple RNS without too much fanfare saying they expect it to add “significant incremental revenue”.
Novacyt keep downplaying so as not to draw too much attention from the media because they know they are in line for multi million pound contracts.
These figures are just confirmation of the RNS from back in July.
I would have loved details like “we’re first in line for this this and this contract”, “we’re eyeing up buying X company” but that’s not how running a public company works.
It has been a good trade buying high 290s and selling when it gets to 320 or higher but one day people trading will get caught out by a tender award announcement.
Even just the usual sales update could give this a boost. Mullis already said he expects H2 to be a lot higher than the first half of the year.
The continued strength on the back of very limited news flow, Paris at 364 now, high of the day 365, bodes very well.
I think we will be making new all time highs within the next couple of months.
PerkinElmer were instrumental in setting up the lighthouse lab for Wales.
https://ir.perkinelmer.com/news-releases/news-release-details/over-200-jobs-announced-part-welsh-lighthouse-lab-facility
They are now doing a similar 150k test per day lab for California.
I’m unsure where Novacyt fits into this other than the fact that it’s all about PCR tests and Perkin own a key patent for that.
https://live.euronext.com/en/product/equities/FR0010397232-ALXP
High of 368 so far today.
Novacyt has made a name for themselves with contracts and contacts at governments worldwide.
Governments will now stockpile for future pandemics so I would say a healthy baseline of sales at least in the tens of millions will be seen for years to come.
It's currently being valued based on sales of £20m per month.
I don't think we will see £100m in a month but I do think £30m to £40m is easily doable. If that's the case I can't see why NCYT won't double from here.